EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F18%3A10375294" target="_blank" >RIV/00216208:11110/18:10375294 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/18:00102047 RIV/00216208:11130/18:10375294 RIV/00216208:11140/18:10375294 RIV/00216208:11150/18:10375294 and 8 more
Result on the web
<a href="https://doi.org/10.1111/crj.12700" target="_blank" >https://doi.org/10.1111/crj.12700</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/crj.12700" target="_blank" >10.1111/crj.12700</a>
Alternative languages
Result language
angličtina
Original language name
EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis
Original language description
IntroductionPrognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized include changes in vital capacity and radiologic findings. However, most of the prognostic studies in IPF are based on clinical studies with preselected IPF populations. Therefore, we decided to analyze the factors influencing IPF prognosis based on the real-practice data from our IPF registry. MethodsData of 514 subjects consecutively entered since 2012 into Czech EMPIRE IPF registry were analyzed. ResultsMedian age of our patient cohort was 67 years (50-82). Median overall survival (OS) of the cohort was 63.1 months. The clinical course of IPF according to FVC (forced vital capacity) changes was stabilized in 32.8% of patients (29.7% according to DLCO [diffuse lung capacity] changes), slowly progressive in 39.5% (45%), rapidly progressive in 23.5% (20.7%); and 1.7% patients had at least one acute exacerbation during follow-up. Deterioration in FVC of 10% at month 12 and in DLCO of 15% at months 12, 18, and 24 influenced the OS significantly. The fast progressors defined by the DLCO decline rate had higher risk of death compared to those defined by the FVC change over time. In multivariate analysis, age 70 years, interstitial HRCT scores 3, and change in DLCO of 15% at month 12 were confirmed as factors negatively influencing OS. ConclusionsDL(CO) changes over time were shown as a better predictor of mortality compared with FVC changes in our study. In our opinion it is necessary to implement the DLCO analysis into clinical trials and routine practice.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30203 - Respiratory systems
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
The Clinical Respiratory Journal
ISSN
1752-6981
e-ISSN
—
Volume of the periodical
12
Issue of the periodical within the volume
4
Country of publishing house
GB - UNITED KINGDOM
Number of pages
10
Pages from-to
1526-1535
UT code for WoS article
000429581600025
EID of the result in the Scopus database
2-s2.0-85045122005